Anna Pagani
Overview
Explore the profile of Anna Pagani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Serra F, Valerio F, Pedrazzoli P, Vigano J, Caccialanza R, Cicognini D, et al.
Drugs Context
. 2025 Feb;
14.
PMID: 40017727
Background: Gastric cancer has a high mortality rate. Therapeutic management must be multidisciplinary to offer the patient the best, personalized strategy. Patients And Methods: We performed an observational study to...
2.
Mauro A, Faverio C, Brizzi L, Mazza S, Scalvini D, Alfieri D, et al.
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004698
Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers, characterized by late diagnosis, rapid progression, and limited therapeutic options. Despite advancements, only 20% of patients are eligible for surgical...
3.
Barcellini A, Molinelli S, Vanoli A, Vitolo V, Fossati P, Vai A, et al.
Tumori
. 2024 Oct;
110(6):470-474.
PMID: 39462835
Purpose: There is debate about the optimal management of borderline resectable (bRe) and resectable (Re) pancreatic ductal adenocarcinoma (PDAC). Both preclinical and clinical evidence showed that carbon ion radiotherapy (CIRT)...
4.
Aquilani R, Brugnatelli S, Maestri R, Iadarola P, Corallo S, Pagani A, et al.
Int J Mol Sci
. 2024 May;
25(10).
PMID: 38791339
Previous studies have documented that FOLFOX and XELOX therapies negatively impact the metabolism of skeletal muscle and extra-muscle districts. This pilot study tested whether three-month FOLFOX or XELOX therapy produced...
5.
Mauro A, Scalvini D, Borgetto S, Fugazzola P, Mazza S, Perretti I, et al.
Cancers (Basel)
. 2024 Feb;
16(4).
PMID: 38398212
Patients presenting with acute colonic obstruction are usually evaluated in the emergency department and multiple specialties are involved in the patients' management. Pre-treatment evaluation is essential in order to establish...
6.
Secondino S, Pedrazzoli P, Basso S, Bossi P, Bianco A, Imarisio I, et al.
Front Immunol
. 2023 Jul;
14:1208475.
PMID: 37497213
Background: Refractory or metastatic nasopharyngeal carcinoma (NPC) patients have a poor prognosis due to the lack of effective salvage treatments and prolonged survival by means of combination chemotherapy being described...
7.
Fugazzola P, Moroni A, Agnoletti V, Catena F, Cobianchi L, Corallo S, et al.
Updates Surg
. 2023 Jul;
75(7):1819-1825.
PMID: 37423956
International guidelines exclude from surgery patients with peritoneal carcinosis of colorectal origin and a peritoneal cancer index (PCI) ≥ 16. This study aims to analyze the outcomes of patients with...
8.
Serra F, Pedrazzoli P, Brugnatelli S, Pagani A, Corallo S, Rosti G, et al.
Drugs Context
. 2022 Nov;
11.
PMID: 36339293
Gastric cancer is the sixth most common malignancy in the world. However, its mortality has been decreasing in the last years thanks to improvement in diagnostics and therapeutics. Nevertheless, the...
9.
Karlen C, Pagani A, Binder C
J Hous Built Environ
. 2022 Aug;
37(3):1367-1408.
PMID: 36042869
The environmental footprint of housing is greatly influenced by the size of a dwelling. Housing size is the result of households' dwelling selections; accordingly, it is critical to consider residential...
10.
Palmeri M, Peri A, Pucci V, Furbetta N, Gallo V, Di Franco G, et al.
Updates Surg
. 2022 Jul;
74(4):1327-1335.
PMID: 35778547
Background: Conventional Right Colectomy with D2 lymphadenectomy (RC-D2) currently represent the most common surgical treatment of right-sided colon cancer (RCC). However, whether it should be still considered a standard of...